Drug Trial Radar · NCT04267848
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,210
Planned (sponsor's estimate)
Start
Jun 16, 2020
Primary completion
Jan 31, 2030
Study completion Jan 31, 2030
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- First posted
- Feb 13, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Conditions
- Lung Non-Small Cell Carcinoma
- Lung Non-Small Cell Squamous Carcinoma
- Lung Non-Squamous Non-Small Cell Carcinoma
- Stage II Lung Cancer AJCC v8
- Stage IIIA Lung Cancer AJCC v8
- Stage IIIB Lung Cancer AJCC v8
Interventions
Biospecimen CollectionProcedure
Undergo blood sample collection
CarboplatinDrug
Given IV
CisplatinDrug
Given IV
Computed TomographyProcedure
Undergo CT
Echocardiography TestProcedure
Undergo ECHO
Gemcitabine HydrochlorideDrug
Given IV
Magnetic Resonance ImagingProcedure
Undergo MRI
Observation ActivityOther
Undergo observation
PaclitaxelDrug
Given IV
PembrolizumabBiological
Given IV
Pemetrexed DisodiumDrug
Given IV
Questionnaire AdministrationOther
Ancillary studies
Primary outcomes
What the sponsor says the trial is designed to measure.
- Disease free survival (DFS)Time frame: From randomization to the first of either disease recurrence or death from any cause, assessed up to 5 years after accrual completion
Locations
1,151 sites in 2 countries. Site status is shown where the registry gives one.
Anchorage Associates in Radiation Medicine
Anchorage, Alaska · Suspended
Anchorage Radiation Therapy Center
Anchorage, Alaska · Suspended
Alaska Breast Care and Surgery LLC
Anchorage, Alaska · Suspended
Alaska Oncology and Hematology LLC
Anchorage, Alaska · Suspended
Alaska Women's Cancer Care
Anchorage, Alaska · Suspended
Anchorage Oncology Centre
Anchorage, Alaska · Suspended
Katmai Oncology Group
Anchorage, Alaska · Recruiting
Providence Alaska Medical Center
Anchorage, Alaska · Suspended
Fairbanks Memorial Hospital
Fairbanks, Alaska · Recruiting
Banner MD Anderson Cancer Center
Gilbert, Arizona · Suspended
Kingman Regional Medical Center
Kingman, Arizona · Suspended
Cancer Center at Saint Joseph's
Phoenix, Arizona · Suspended
Banner Boswell Medical Center
Sun City, Arizona · Suspended
Banner University Medical Center - Tucson
Tucson, Arizona · Active not recruiting
University of Arizona Cancer Center-North Campus
Tucson, Arizona · Active not recruiting
Mercy Hospital Fort Smith
Fort Smith, Arkansas · Suspended
CHI Saint Vincent Cancer Center Hot Springs
Hot Springs, Arkansas · Suspended
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas · Recruiting
Kaiser Permanente-Anaheim
Anaheim, California · Recruiting
Kaiser Permanente-Deer Valley Medical Center
Antioch, California · Recruiting
Mission Hope Medical Oncology - Arroyo Grande
Arroyo Grande, California · Suspended
PCR Oncology
Arroyo Grande, California · Suspended
Sutter Auburn Faith Hospital
Auburn, California · Recruiting
Sutter Cancer Centers Radiation Oncology Services-Auburn
Auburn, California · Suspended
Kaiser Permanente-Baldwin Park
Baldwin Park, California · Recruiting
Kaiser Permanente-Bellflower
Bellflower, California · Recruiting
Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California · Recruiting
Providence Saint Joseph Medical Center/Disney Family Cancer Center
Burbank, California · Suspended
Mills-Peninsula Medical Center
Burlingame, California · Suspended
Sutter Cancer Centers Radiation Oncology Services-Cameron Park
Cameron Park, California · Suspended
Eden Hospital Medical Center
Castro Valley, California · Suspended
John Muir Medical Center-Concord
Concord, California · Active not recruiting
Sutter Davis Hospital
Davis, California · Suspended
City of Hope Comprehensive Cancer Center
Duarte, California · Active not recruiting
Epic Care-Dublin
Dublin, California · Active not recruiting
Kaiser Permanente Dublin
Dublin, California · Recruiting
Bay Area Breast Surgeons Inc
Emeryville, California · Active not recruiting
Epic Care Partners in Cancer Care
Emeryville, California · Active not recruiting
Kaiser Permanente-Fontana
Fontana, California · Recruiting
Kaiser Permanente-Fremont
Fremont, California · Recruiting
Showing 40 of 1,151 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.